On Thursday 16 January, the winners of the 1st call for projects “ANALGESIA – Pharma Domes: pain and animal health” launched in June 2019 were announced. The selected project is a Franco-Brazilian study project that evaluates different physiotherapy methods for the immediate relief of myofascial pain in dogs. On the initiative of Denise Tabacchi Fantoni, from the Department of Veterinary Surgery at the University of São Paulo (Brazil), and Maira Rezende Formenton, doctoral student, the practical work of the study will be carried out by Karine Portier’s team from VetAgro Sup Lyon with dogs suffering from osteoarthritis presented for consultation at the Centre Hospitalier Universitaire Vétérinaire (CHUV).

Karine Portier, present at the evening event organized at Vetagro Sup Lyon, and her two co-laureates who attended the event by video-conference in São Paulo, were presented with a cheque for €18,000 by Anne Chauder, President of the Dômes Pharma Group. By joining forces with the ANALGESIA Institute, the Group’s objective is to ensure that knowledge, awareness and treatment of animal pain can benefit from the latest research advances. The “ANALGESIA – Dômes Pharma: pain and animal health” prize will be awarded every year for 5 years.

The main objective of the MPSAH study (for Myofascial Pain Syndrome dog human patients) winning this first edition is to map trigger points in arthritic dogs using different diagnostic tools that will then be compared. The second objective is to compare the mapping and characteristics of PMS in humans and dogs. The third objective is to use the results of this study to complete a veterinary exercise thesis (DMV) on pain recognition techniques in animals (e-learning).

The prize was awarded by ANALGESIA and DÔMES PHARMA at the end of a Symposium on animal pain during which Professor Alain ESCHALIER, President of the ANALGESIA Institute, Thierry POITTE, veterinarian, member of the jury and founder of the CAPDouleur Network, and Norin CHAI, chief veterinarian of the Jardin des Plantes zoo, spoke.

Comments are closed.